Commercial coverage
Does Blue Cross Blue Shield of Illinois cover Zepbound?
Zepbound (tirzepatide) for weight loss / obesity — the Blue Cross Blue Shield of Illinois prior-authorization rule, source-cited.
Blue Cross Blue Shield of Illinois Zepbound PA criteria
Anti-obesity GLP-1 coverage is an OPTIONAL employer-elected benefit; most plans don't cover GLP-1s for weight loss, so for many members it is not a covered benefit (criteria apply only where elected).
Covers Wegovy, Zepbound, Saxenda, plus Foundayo.
Initial (all met): age within FDA labeling; no FDA contraindication; not combined with another weight-loss agent (Contrave, phentermine, Qsymia, Xenical) or another GLP-1; adults BMI >=30, OR >=1 weight-related comorbidity (HTN, T2DM, OSA, CVD, dyslipidemia), OR BMI >=25 if South/Southeast/East Asian descent; pediatric (12-17) BMI >=95th pctl, OR >=30, OR >=85th pctl + >=1 comorbidity.
Lifestyle: on AND inadequate response to low-calorie diet + increased activity + behavioral modification for a MINIMUM of 6 MONTHS prior, continued during therapy.
Separate Wegovy MACE pathway: established CVD + BMI >=27.
Renewal: general WM >=5%; Saxenda adults >=4% (peds >=1% BMI); Wegovy adults >=5% (or <52 wks on max-tolerated dose; peds >=5% BMI + current BMI >=85th pctl); Zepbound/Foundayo >=5%.
Approval: BCBSIL FI/HIM/ASO-Cost 12mo; others initial Wegovy/Zepbound/Foundayo 12mo, Saxenda adults 4mo/peds 5mo; renewals 12mo.
Source: HCSC/Prime GLP-1 Agonists PAQL Program Summary (eff. 05-11-2026) & Weight Management PA Fax Form 7319 HCSC WEMT 0526 (rev. May 2026). View cited GLP-1 policy reference →
Note: tirzepatide is also sold as Mounjaro for type 2 diabetes, which Blue Cross Blue Shield of Illinois evaluates under a separate type 2 diabetes policy (not this one) — see does Blue Cross Blue Shield of Illinois cover Mounjaro?. Coverage follows the brand's FDA indication, not the molecule.
Frequently asked
- Does Blue Cross Blue Shield of Illinois cover Zepbound for weight loss / obesity?
- Varies by plan — PA required where covered. Anti-obesity GLP-1 coverage is an OPTIONAL employer-elected benefit; most plans don't cover GLP-1s for weight loss, so for many members it is not a covered benefit (criteria apply only where elected). See the full source-cited criteria above. Per HCSC/Prime GLP-1 Agonists PAQL Program Summary (eff. 05-11-2026) & Weight Management PA Fax Form 7319 HCSC WEMT 0526 (rev. May 2026), as of 2026 (diabetes ProgSum eff. 05-11-2026; WM fax form rev. May 2026; accessed 2026-06-15) — confirm the member's current plan policy.
d3rx does not hold plan-specific pharmacy formularies or PBM prior-auth grids, so it cannot confirm a particular plan's GLP-1 coverage, tier, or PA criteria. The guidance below is the general, source-cited rule; confirm the specific plan's pharmacy formulary / PA policy for a binding answer.
Check Zepbound for another payer — or draft the PA
Run Zepbound + any payer in the GLP-1 PA lookup, or have Ask D3 draft a Blue Cross Blue Shield of Illinois-ready prior-authorization request with the right criteria and codes — free, no signup.